AIDS WEEKLY Plus - May 2006Important note: Information in this article was accurate in May 2006. The state of the art may have changed since the publication date.
Click here to return to AIDS WEEKLY PLUS main menu

DonateNow
Print this Article

HIV-1/HTLV-II Coinfection: HIV-1/HTLV-II coinfection associated with greater immunodeficiency

AIDSWEEKLY Plus; Monday, May 15, 2006
Staff Medical Writers


NewsRx -- HIV-1/HTLV-II coinfection is associated with greater immunodeficiency.

According to a recently published report from Mexico, "The HTLV-II infection has been reported in patients with HIV infection as often in asymptomatic as those with acquired immunodeficiency syndrome (AIDS).

"The aim of this study was to determine the prevalence of HTLV-II infection in a group of patients infected by HIV in our region, as well as determining the risk factors associated with HTLV-II transmission in this group of patients and its impact on the clinical course of HIV infection."

"A cross-sectional study was carried out to determine the prevalence of coinfection of HIV-I and HTLV-II among 192 patients from Yucatan, Mexico. Serum specimens were tested for HTLV antibodies by an enzyme-linked immunosorbent assay (ELISA) test. Positive results were confirmed and typed by Western blot," researchers said.

C.J. Castro-Sansores and colleagues at University of Autonoma Yucatan in Merida reported, "Twenty four (12.5%) patients were confirmed with antibodies for HTLV-II, but none had antibodies for HTLV-I.

"Specific risk factors for HTLV-II transmission were not identified. Candidiasis (42 vs. 12%, p=0.0004) and more than two defining entities of AIDS (37 vs. 18%, p=0.02) was observed with greater prevalence in the group coinfected."

"In our study," researchers concluded, "higher frequency of candidiasis and a larger number of AIDS-defining pathologies were observed in the coinfected patients, suggesting that coinfection is associated with greater immunodeficiency."

Castro-Sansores and colleagues published their study in Archives of Medical Research (Coinfection by the human T-Cell lymphotropic virus type II in patients infected by the human immunodeficiency virus in Yucatan, Mexico. Arch Med Res. 2006 Apr;37(3):365-9).

For additional information, contact C.J. Castro-Sansores, University of Autonoma Yucatan, Hematology Laboratory, Reg Research Center Dr. Hideyo Noguchi, Av Itzaes 490 & 59, Center, Merida 97000, Yucutan, Mexico.

The publisher's contact information for the journal Archives of Medical Research is: Elsevier Science Inc., 360 Park Avenue South, New York, NY 10010-1710, USA.

Keywords: Merida, Mexico, HIV-1/HTLV-II Coinfection, Immunodeficiency, AIDS-Defining Illness.

This article was prepared by AIDS Weekly editors from staff and other reports.

Reference

Castro-Sansores CJ, Santos-Rivero A, Gonzalez-Martinez P, et al., "Co-infection by the human T-cell lymphotropic virus type II in patients infected by the human immunodeficiency virus in Yucatan, Mexico", Arch Med Res. 2006 Apr;37(3):365-9.

PubMED Related articles Search

2006-05-15
AW060507


Copyright © 2006 - Charles Henderson, Publisher. All rights Reserved. Permission to reproduce granted to AEGIS by Charles W. Henderson. Authorization to reproduce for personal use granted granted by C. W. Henderson, Publisher, provided that the fee of US$4.50 per copy, per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, Massachusetts 01970, USA. Published by Charles Henderson, Publisher. Editorial & Publishing Office: P.O. Box 5528, Atlanta, GA 30307-0528 / Telephone: (800) 633-4931; Subscription Office: P.O. Box 830409, Birmingham, AL 35283-0409 / FAX: (205) 995-1588 http://www.newsrx.net

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, Bridgestone/Firestone Charitable Trust, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright © 1980,2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.